TU-Professorin Sina Bartfeld in den Vorstand des German Stem Cell Network berufen

Die Stammzellforscherin will die Brücke zwischen Grundlagenwissenschaft und Anwendung auf diesem Gebiet stärken

Background Research:

Professor Sina Bartfeld is a leading figure in stem cell research, with years of experience and numerous scientific papers to her credit. Her work has centered predominantly on understanding the properties and potentials of stem cells, especially how they can be employed in various therapeutic interventions.

The German Stem Cell Network (GSCN) is an association created to unite all active researchers, clinicians and experts in the field of stem cell research across Germany. The organization aims not only to facilitate closer collaboration between researchers but also intends to promote public understanding of stem cells.

FAQs:

1. Q: Who is Professor Sina Bartfeld?
A: She is a renowned professor who specializes in the field of Stem Cell Research.

2. Q: What role has she been appointed for within the German Stem Cell Network?
A: Professor Bartfeld has been called into the Board (Vorstand) of this network which indicates a leadership role where she will be consistently involved with decision-making processes related to overall strategy as well as day-to-day operations until her tenure ends.

3. Q: What are her plans or focus areas within this new role?
A: As part of her newly appointed position, Professor Bartfeld aims at bridging gaps between basic science research and practical applications in the field through strategic decisions that foster productivity and impactfulness throughout their work-flow system.

4. Q: When was she assigned this position?
A: She was made an official part member on 27th September 2024

5. Q: How does this appointment impact or contribute to scientific community over-all?
A:Facing numerous challenges from ethical guidelines abreast technological advancements, clearly communicated directives under leading experts like Professor Bartfed will help consolidate efforts into effective strategies tackling pressing issues associated genetic therapy; ensuring resources are optimally utilized for both public benefit and scholarly advancement.

6.Q :Where can I find more details about this announcement?
A: Additional information regarding Professor Bartfeld’s new appointment can be found on the official press release: http://idw-online.de/de/news840393

Originamitteilung:

Die Stammzellforscherin will die Brücke zwischen Grundlagenwissenschaft und Anwendung auf diesem Gebiet stärken

share this recipe:
Facebook
Twitter
Pinterest

Weitere spannende Artikel

Neuartige Methode zur Tumorbekämpfung: Carl-Zeiss-Stiftung fördert Projekt der Hochschule Aalen mit einer Million Euro

Die bisherige Krebstherapie effizienter gestalten bei deutlicher Reduzierung der Nebenwirkungen auf gesundes Gewebe – dies ist das Ziel eines Projekts von Prof. Dr. Andreas Walter, der an der Hochschule Aalen lehrt und forscht. Gefördert wird es mit einer Million Euro von der Carl-Zeiss-Stiftung. Hierzu entwickelt der Biophysiker mit seinem Team neuartige Nanopartikel aus Gold. Die Partikel setzen Strahlen- und Chemotherapie gleichzeitig ein und töten die Krebszellen gezielt ab. Für die Auswertung werden skalenübergreifende bildgebende Verfahren an der Hochschule Aalen entwickelt.

Read More